1. Home
  2. FBIOP vs TVAIU Comparison

FBIOP vs TVAIU Comparison

Compare FBIOP & TVAIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIOP
  • TVAIU
  • Stock Information
  • Founded
  • FBIOP N/A
  • TVAIU N/A
  • Country
  • FBIOP United States
  • TVAIU United States
  • Employees
  • FBIOP 101
  • TVAIU N/A
  • Industry
  • FBIOP Biotechnology: Pharmaceutical Preparations
  • TVAIU Blank Checks
  • Sector
  • FBIOP Health Care
  • TVAIU Finance
  • Exchange
  • FBIOP Nasdaq
  • TVAIU Nasdaq
  • Market Cap
  • FBIOP N/A
  • TVAIU N/A
  • IPO Year
  • FBIOP N/A
  • TVAIU 2025
  • Fundamental
  • Price
  • FBIOP $6.93
  • TVAIU $10.10
  • Analyst Decision
  • FBIOP
  • TVAIU
  • Analyst Count
  • FBIOP 0
  • TVAIU 0
  • Target Price
  • FBIOP N/A
  • TVAIU N/A
  • AVG Volume (30 Days)
  • FBIOP N/A
  • TVAIU N/A
  • Earning Date
  • FBIOP N/A
  • TVAIU N/A
  • Dividend Yield
  • FBIOP N/A
  • TVAIU N/A
  • EPS Growth
  • FBIOP N/A
  • TVAIU N/A
  • EPS
  • FBIOP N/A
  • TVAIU N/A
  • Revenue
  • FBIOP N/A
  • TVAIU N/A
  • Revenue This Year
  • FBIOP N/A
  • TVAIU N/A
  • Revenue Next Year
  • FBIOP N/A
  • TVAIU N/A
  • P/E Ratio
  • FBIOP N/A
  • TVAIU N/A
  • Revenue Growth
  • FBIOP N/A
  • TVAIU N/A
  • 52 Week Low
  • FBIOP N/A
  • TVAIU N/A
  • 52 Week High
  • FBIOP N/A
  • TVAIU N/A
  • Technical
  • Relative Strength Index (RSI)
  • FBIOP 36.60
  • TVAIU N/A
  • Support Level
  • FBIOP $6.56
  • TVAIU N/A
  • Resistance Level
  • FBIOP $7.23
  • TVAIU N/A
  • Average True Range (ATR)
  • FBIOP 0.52
  • TVAIU 0.00
  • MACD
  • FBIOP -0.09
  • TVAIU 0.00
  • Stochastic Oscillator
  • FBIOP 21.08
  • TVAIU 0.00

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

About TVAIU Thayer Ventures Acquisition Corporation II Unit

Thayer Ventures Acquisition Corp II is a blank check company.

Share on Social Networks: